Old Web
English
Sign In
Acemap
>
authorDetail
>
Lihong Peng
Lihong Peng
Nanchang University
Lung cancer
Proportional hazards model
Oncology
Immunotherapy
Neutrophil to lymphocyte ratio
2
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Survival and prognosis analyses of concurrent PIK3CA mutations in EGFR mutant non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
2021
American Journal of Cancer Research
Xiaotong Qiu
Yong Wang
Fen Liu
Lihong Peng
Chen Fang
Xiaoyin Qian
Xinwei Zhang
Qian Wang
Zhehao Xiao
Renfang Chen
Shangkun Yuan
Yong Li
Show All
Source
Cite
Save
Citations (1)
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors.
2020
Cancer Immunology, Immunotherapy
Lihong Peng
Yong Wang
Fen Liu
Xiaotong Qiu
Xinwei Zhang
Chen Fang
Xiaoyin Qian
Yong Li
Show All
Source
Cite
Save
Citations (26)
1